eNews July 19, 2022

The latest news affecting you and your customers… from the Independent Medical Specialty Dealers Association

 

IMDA eNews readers: The staff will be at the 2022 IMDA/HIRA Annual Conference at The Eaglewood Resort & Spa Chicago in Itasca, Illinois, from July 25 through July 27. We’d like to meet you there! It’s not too late to register. For assistance with room arrangements at Conference prices, call HIRA Executive Administrator Shannon Reddish at (303) 756-8115. Our next newsletter will be in your inbox Aug. 2.

 

Inhaled nitric oxide for neonates

BeyondAir Inc., a Garden City, New York, company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, reported that the FDA approved LungFit® PH to treat term and near-term neonates with hypoxic respiratory failure (often referred to as persistent pulmonary hypertension of the newborn, or PPHN). The technology is said to use a patented technology to generate unlimited on-demand nitric oxide from ambient air and deliver it to a ventilator circuit, regardless of dose or flow.

 

Microbot clears stroke-related bleeding

A new treatment for strokes caused by bleeding in the brain that uses a magnetically controlled microrobot-enabled self-clearing catheter has been shown to be 86% effective in animal models, reports Purdue University. Hyowon “Hugh” Lee, a Purdue University associate professor from the Weldon School of Biomedical Engineering, created the magnetically controlled microdevice that removes blood accumulating in the brain during a stroke. “Currently there is no great therapeutic solution for intraventricular hemorrhage,” Dr. Albert Lee from Goodman Campbell Brain and Spine in Carmel, Indiana, was quoted as saying. “The only other option is blood clot-dissolving drugs that have undesirable risks.”

 

Antimicrobial resistance rose during pandemic

The COVID-19 pandemic pushed back years of progress made combating antimicrobial resistance in the United States, according to the Centers for Disease Control and Prevention. CDC reports that resistant hospital-onset infections and deaths both increased at least 15% during the first year of the pandemic. Antifungal-resistant threats rose in 2020, too, including Candida auris—which increased 60% overall—and Candida species (excluding Candida auris), with a 26% increase in infections in hospitals.

 

 

Independent agency for food safety

A recently introduced bill would take away the responsibility for food safety from the U.S. Food and Drug Administration and place it in the hands of a new, independent federal agency, if a bill introduced by U.S. Senator Richard Durbin (D-Ill.) and Representative Rosa DeLauro (D-Conn.) is passed. The Food Safety Administration Act of 2022 would unify existing FDA food programs within the newly established Food Safety Administration: the Center for Food Safety and Applied Nutrition, the Center for Veterinary Medicine, and the Office of Regulatory Affairs. Durbin and DeLauro say the change is necessary because inattention to food safety has led to recalls, supply chain disruptions, inflation, and consumer illness and death.